Department of Anesthesiology, New York Presbyterian Hospital, Weill-Cornell Medical Center, New York, NY 10065, USA.
J Clin Anesth. 2010 Sep;22(6):450-3. doi: 10.1016/j.jclinane.2009.05.008.
A recombinant human antithrombin (rhAT; generic name: antithrombin Alfa) has recently been developed. A 37 year-old parturient with hereditary antithrombin deficiency, receiving rhAT infusion therapy, who successfully received an epidural catheter for analgesia and anesthesia during labor and cesarean delivery, is presented.
最近开发了一种重组人抗凝血酶（rhAT；通用名：抗凝血酶 Alfa）。本文报告了 1 例 37 岁产妇，患有遗传性抗凝血酶缺乏症，接受 rhAT 输注治疗，在分娩和剖宫产期间成功接受了硬膜外导管镇痛和麻醉。
Zotero 插件